Correlation Between AzureWave Technologies and Genovate Biotechnology

Can any of the company-specific risk be diversified away by investing in both AzureWave Technologies and Genovate Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AzureWave Technologies and Genovate Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AzureWave Technologies and Genovate Biotechnology Co, you can compare the effects of market volatilities on AzureWave Technologies and Genovate Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AzureWave Technologies with a short position of Genovate Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of AzureWave Technologies and Genovate Biotechnology.

Diversification Opportunities for AzureWave Technologies and Genovate Biotechnology

-0.74

Correlation Coefficient

AzureWave Technologies  Genovate Biotechnology

Pay attention - limited upside

The 3 months correlation between AzureWave and Genovate is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding AzureWave Technologies and Genovate Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genovate Biotechnology and AzureWave Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AzureWave Technologies are associated (or correlated) with Genovate Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genovate Biotechnology has no effect on the direction of AzureWave Technologies i.e., AzureWave Technologies and Genovate Biotechnology go up and down completely randomly.

Pair Corralation between AzureWave Technologies and Genovate Biotechnology

Assuming the 90 days trading horizon AzureWave Technologies is expected to generate 6.53 times more return on investment than Genovate Biotechnology. However, AzureWave Technologies is 6.53 times more volatile than Genovate Biotechnology Co. It trades about 0.14 of its potential returns per unit of risk. Genovate Biotechnology Co is currently generating about -0.32 per unit of risk. If you would invest  5,550  in AzureWave Technologies on October 7, 2024 and sell it today you would earn a total of  700.00  from holding AzureWave Technologies or generate 12.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

AzureWave Technologies  vs.  Genovate Biotechnology Co

AzureWave Technologies

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in AzureWave Technologies are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, AzureWave Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Genovate Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with AzureWave Technologies and Genovate Biotechnology

The main advantage of trading using opposite AzureWave Technologies and Genovate Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AzureWave Technologies position performs unexpectedly, Genovate Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovate Biotechnology will offset losses from the drop in Genovate Biotechnology's long position.

The idea behind AzureWave Technologies and Genovate Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.